# Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage

> **NCT01824043** · PHASE4 · UNKNOWN · sponsor: **Hospital Regional de São José - Dr. Homero de Miranda Gomes** · enrollment: 20 (estimated)

## Conditions studied

- Diabetic Retinopathy
- Vitreous Hemorrhage

## Interventions

- **DRUG:** intravitreal ranibizumab injections

## Key facts

- **NCT ID:** NCT01824043
- **Lead sponsor:** Hospital Regional de São José - Dr. Homero de Miranda Gomes
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2013-09
- **Final completion:** 2013-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2013-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01824043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01824043, "Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01824043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*